4Life Appoints New Chief Scientific Officer
4Life executives recently appoint David Vollmer, PhD, as the company’s Chief Scientific Officer.
Dr. Vollmer joined 4Life in 2013 with more than fifteen years of experience in quality control and analytical laboratory management, primarily in the pharmaceutical industry. Since joining 4Life, Dr. Vollmer has been responsible for numerous quality processes, as well as the implementation of 4Life’s analytical laboratory which validates the potency, purity, and quality of all 4Life products.
President and CEO Steve Tew: “Dr. Vollmer has made valuable contributions to the quality and integrity of 4Life Transfer Factor® and other 4Life products. I look forward to his leadership as our new Chief Scientific Officer.”
Previously, Dr. Vollmer served as the company’s Vice President of Quality and Analytical Services. In addition to responsibilities that included the 4Life analytical laboratory, he also helped oversee cGMP (Current Good Manufacturing Practices) compliance, stability testing, product specifications and ingredient identification, Standard Operating Procedure (SOP) implementation, and technical and administrative leadership.
Dr. Vollmer: “4Life is a world leader in the science of supplementation. This includes not only controlling the quality of the products we develop, but also ensuring the ongoing scientific research and innovative formulations the company is known for producing. It’s an honor to assume this new role and join our highly talented team of scientists and product formulators. I look forward to collaborating with the many doctors and members of the research and development team who work in-house and on our Health Sciences Advisory Board.”
Dr. Vollmer’s appointment is the latest news in a series of scientific growth-related company announcements, including the company’s newest patent and the construction of a new, state-of-the-art manufacturing facility.
Founder and Chairman of the Board David Lisonbee: “Dr. Vollmer is an incredible scientist and proven leader. His opportunity for innovation is greater now than ever before. I’m excited about the contributions he will make to 4Life’s foundation of science as he leads our research and development department in the future.”
In 1998, 4Life Founders David and Bianca Lisonbee launched the company’s flagship immune system support product, 4Life Transfer Factor. As the first network marketing company to do so, 4Life’s leading group of doctors, scientists, and researchers continue to advance immune system science with innovations in product formulation, production standards, delivery methods, and more.
Today, people in more than 50 countries enjoy the immune system support of 4Life products.
Get more information, facts and figures about 4Life, click here for the 4Life overview.